Posted in General Business 30+ days ago.
Type: Full-Time
Location: Framingham, Massachusetts
Company Overview
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic partnerships with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations in Boston, Massachusetts and San Francisco, California, and business offices in London, United Kingdom.
Position Summary
Our QC team is looking for an enthusiastic individual to work at our state-of-the-art manufacturing facility in Framingham, MA. The Senior QC Analyst is a valuable member of the Quality Control-Bioanalytical team that will coordinate and perform in-process and final product testing of novel cell-based drug therapies and AAV products. The successful candidate will perform flow cytometry assays as well as various biochemical, biophysical, molecular biology, and compendial tests in a GMP environment. In addition, the QC Analyst will lead analytical method transfer and validation projects. The QC Analyst-Flow Cytometry reports to the QC Bioanalytical Sr. Manager.
Responsibilities
To view our Privacy Statement, please click the following link: http://www.crisprtx.com/about-us/privacy-policy
W.B. Mason Company, Inc.
|
Bose Corporation
|
Beacon Hill Staffing Group, LLC
|